Featuring in-depth conversations that explore cutting edge research and analysis from the Institute of Translational Medicine, University of Liverpool. Each episode features our academic experts discussing research in their specialist field.
This podcast series, produced in collaboration with the University of Liverpool online, provides a quick route to insider knowledge on new trends and upcoming key issues. You can view the full University of Liverpool Podcast series here.
Episode: Do we know the right dose of medicine for children?Paediatric medicine faces a troubling challenge. For good ethical reasons, scientists have long been reluctant to experiment on children. As a result, many of the oldest and most common medications used in pediatric medicine have not been tested on the youngest patients. This means there is very little good quality research on efficacy or proper dosage.
This concerns Dr Dan Hawcutt. He’s a Senior Lecturer Paediatric Clinical Pharmacology at the University of Liverpool and an Honorary Consultant Paediatrician at Alder Hey Children’s Hospital who wants to further what we know about the medicines we give to children.
Episode: What if medicine becomes a lot more personal?
It might seem a bit farfetched but someday soon we might all carry in our wallets a little card, something like a credit card except this card will carry our entire genetic code. It’s something you would hand over to your doctor or that doctors would look for if you ended up in hospital.
Another possibility is that your doctor might have your genetic profile on file, right there beside your address, your age and your weight.
According to Professor Sir Munir Pirmohamed healthcare is set to get a lot more personal and that’s a good thing.
Episode: Who stopped the Ebola outbreak?
Dr Calum Semple shares his experience working in Sierra Leone during the Ebola crisis. It’s a harrowing story that offers some surprising lessons.
The large scale Western medical intervention, the type Dr Semple was involved in, might not have been the crucial factor in conquering the outbreak – and certainly not as key as we may have thought. Rather, when reflecting on his research and his experiences, Calum suggests that public health messages concerning the burial of infected persons were vital in curbing the spread of the epidemic.
Episode: Nano-medicine shrinks the cost of HIV treatment
Professors Steve Rannard and Andrew Owen are using nano-technology to make HIV medicine more effective and less expensive. Nanomedicine builds tiny particles of medication designed to drive the drug into the bloodstream more effectively.
Less medicine means lower costs for treatment, which could greatly increase the number of HIV patients that can receive therapy in low to middle income countries.
Episode: Follow Your Nose
Professor Chris Probert leads a team that’s invented a machine that can reliably detect the early stages of cancer in a patient with nothing more than a sniff of small sample.
For some cancers this has the potential to dramatically simplify the detection of tumours. It offers an alternative test that is not only much more comfortable for patients but also potentially much more accurate.